A phase I double-blind, crossover, placebo-controlled trial investigating TM 38837 for the treatment of obesity and type 2 diabetes mellitus.

Trial Profile

A phase I double-blind, crossover, placebo-controlled trial investigating TM 38837 for the treatment of obesity and type 2 diabetes mellitus.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2010

At a glance

  • Drugs TM 38837 (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors 7TM Pharma
  • Most Recent Events

    • 15 Nov 2010 New trial record
    • 11 Nov 2010 This trial has been successfully completed, according to a 7TM Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top